- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04133129
Effects of HIIT on Metabolic Syndrome
October 18, 2019 updated by: Ismael Serrablo, Coventry University
Study of the Effects of a Structured Training Program on People at Risk of Developing Metabolic Syndrome
The project aims to find out the differences between two different types of structured training interventions have on the lipid profile of persons with diagnosed dyslipidemia.
Each training intervention will last for 12 weeks.
Subjects participating in the project will undergo a series of tests before and after the training intervention which will allow us to make conclusions.
Study Overview
Status
Unknown
Detailed Description
The purpose of this project is to compare the effect that two different types of aerobic training modes have on the lipid profile of subjects with pre-symptoms of metabolic syndrome.
One training mode will involve High-Intensity Interval Training and the other will involve medium intensity continuous training.
The desired outcomes of this project are to know the effects of both modes of training have on the long-term on the lipid profile in order to help develop a nonpharmacologic alternative to prevent or treat metabolic syndrome and to know how affective and enjoyment responses are affected by the different modes of training.
The Project lasts for 16 weeks.
Training will take place during weeks 3 and 14 of the project.
The project will be described fully to the participants during the 1st week.
In addition to this, their rights as participants will be explained in addition to any possible ethical issues that might require clarifying.
Once the subjects have agreed to take part in the research they will undergo a series of tests in order to asses their cardiorespiratory fitness and their lipids profile.
Before starting the training intervention participants will be randomly assigned to one of the 3 different groups; Control, Medium Intensity Continuous Training and Low Volume High-Intensity Interval Training.
Between weeks 3 and 14 subjects will take part in 3 training sessions per week.
At week 15 and 16 subjects will undergo the same tests as during week 1 and 2.
Study Type
Interventional
Enrollment (Anticipated)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ismael Serrablo, MSc
- Phone Number: 0034652950339
- Email: serrabli@uni.coventry.ac.uk
Study Locations
-
-
-
Madrid, Spain, 28003
- CDM GO fit Vallehermoso
-
Principal Investigator:
- Ismael Serrablo, MsC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Fasted Blood Glucose >100 mg/dL
- Total Cholesterol >200 mg/dL
- Blood Pressure >130/90 mmHg
- Do not partake in more than 150 min/week of moderate to vigorous exercise
Exclusion Criteria:
- Existing or past medical history of vascular disease, cancer, diabetes, osteoporosis, neurological, kidney, pulmonary, digestive (Coeliac disease), thyroidal disease.
- Musculoskeletal injuries
- Neuromuscular disorders or injuries
- Individuals with a pacemaker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: LV-High Intensity Interval Training
2 x 4 minutes at 85%-95% of Heart rate max.
|
On a treadmill, a 2 minute warm-up will be followed by 2 bouts of 4 minutes at an intensity between 85% and 95% of Maximum Heart Rate (HRmax) interspersed by a 2 minutes recovery bout at 70% of heart rate max, followed by a 3 minutes Cool Down
Other Names:
|
Experimental: Moderate Intensity Continuous Training
1 x 45 minutes at 65%-75% of Heart rate max.
|
On a treadmill,a 2-minute warm-up will be followed by 45 minutes at 65%-75% of Heart Rate max followed by 3 minutes cool down.
Other Names:
|
No Intervention: Control Group
They will not be prescribed any training and will be asked to continue with their normal lifestyle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biochemical: Lipid Profile
Time Frame: 0 to 12 weeks
|
Evaluate change in Very Low-Density Lipoproteins (VLDL), High Density Lipoprotein (HDL), and Low-Density Lipoprotein (LDL) in (mg/dl) with Liposcale® test, an advanced lipoprotein test based on 2D Nuclear Magnetic Resonance (NMR).
|
0 to 12 weeks
|
Blood Pressure (mmHg)
Time Frame: 0 to 12 weeks
|
Evaluate change in Systolic and Diastolic Blood Pressure
|
0 to 12 weeks
|
Cardiorespiratory Fitness (ml/kg/min)
Time Frame: 0 to 12 weeks
|
Evaluate change in maximal oxygen uptake (VO2max) via breath by breath analysis performed on a treadmill.
|
0 to 12 weeks
|
Changes in Body Composition (kg)
Time Frame: 0 to 12 weeks
|
Evaluate changes in Fat-free mass, fat mass, skeletal muscle mass measured by bio-electrical impedance analysis.
|
0 to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in exercise enjoyment
Time Frame: 0 to 12 weeks
|
The investigators will assess perceived exercise enjoyment at baseline and post intervention using The Physical Activity Enjoyment Scale (PACES).
(PACES) is an 18-item measure, scored on a 7-point bipolar scale based on the instruction; "Please rate how you feel at the moment about the physical activity you have been doing:"
|
0 to 12 weeks
|
Change in Behavioural Regulations in Exercise Questionnaire-2 (BREQ-2) over time
Time Frame: 0 to 12 weeks
|
Behavioural Regulations in Exercise Questionnaire-2 (BREQ-2) is a 19 item self-report scale.
It uses a Likert-type scale of 5 points, where 0 = not true for me and 4 = very true for me
|
0 to 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Elizabeth Horton, PhD, Coventry University
- Study Director: Alfonso Jimenez, PhD, GOfit and Sheffield Hallam University
- Principal Investigator: Ismael Serrablo, MSc, Coventry University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2019
Primary Completion (Anticipated)
March 2, 2020
Study Completion (Anticipated)
March 31, 2020
Study Registration Dates
First Submitted
October 16, 2019
First Submitted That Met QC Criteria
October 18, 2019
First Posted (Actual)
October 21, 2019
Study Record Updates
Last Update Posted (Actual)
October 21, 2019
Last Update Submitted That Met QC Criteria
October 18, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P72554
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Low Volume-High Intensity Interval Training
-
Horus UniversityRecruitingOverweight | Overweight and ObesityEgypt
-
Riphah International UniversityCompletedOverweight and ObesityPakistan
-
Riphah International UniversityCompleted
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
University of PrimorskaS2P, Science to Practice, Ltd.Unknown
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Hacettepe UniversityAnkara UniversityRecruitingLung Cancer | Non Small Cell Lung CancerTurkey
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland